タグ: 製薬

KSK Corporation and Hitachi, Ltd. have begun a collaborative creation project to utilize advanced digital technologies to digitally…

Eisai Co., Ltd. and Biogen Inc. have started a rolling supplemental Biologics License Application (sBLA) with the U.S.…

MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the two companies have signed an exclusive global…

Eisai Co., Ltd. announced that it has received orphan drug designation for anticancer agent the EZH2 inhibitor tazemetostat…

Eisai Co., Ltd. and Biogen Inc. shared that LEQEMBI (lecanemab), an anti-amyloid beta monoclonal antibody, launched in Austria…

JDSC Co., Ltd. has launched a smart factory project to advance pharmaceutical manufacturing processes in collaboration with Taiho…

Elix, Inc., a Japan-based AI drug discovery company, is pleased to announce that KYORIN Pharmaceutical Co., Ltd. has…

Eisai Co., Ltd. DAYVIGO® (lemborexant) has been approved in China, where it’s sold as “达卫可®.” The drug will…

Pfizer Inc. and Astellas Pharma Inc. announced positive topline results from the Phase 3 EV-303 clinical trial (also…

Nxera Pharma has launched a wide range of unique treatments. These aim to create next-generation therapies for obesity…

Lantern Pharma Inc., an artificial intelligence (AI) company developing targeted cancer therapies using its proprietary RADR® AI platform,…

Protagenic Therapeutics, Inc. announces that on July 18, 2025, the Japanese Patent Office granted Patent JP 7714571B, a…